FMP

FMP

Enter

ECX.DE - Epigenomics AG

Financial Summary of Epigenomics AG(ECX.DE), Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of

photo-url-https://financialmodelingprep.com/image-stock/ECX.DE.png

Epigenomics AG

ECX.DE

XETRA

Inactive Equity

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

1.6 EUR

-0.01 (-0.625%)

About

ceo

Mr. Gregory K. Hamilton

sector

Healthcare

industry

Medical - Diagnostics & Research

website

https://www.epigenomics.com

exchange

XETRA

Description

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was foun...

CIK

N/A

ISIN

DE000A11QW50

CUSIP

D2552Q171

Address

Geneststrasse 5

Phone

49 30 243 450

Country

DE

Employee

36

IPO Date

Jul 19, 2004

Summary

CIK

-

Exchange

XETRA

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

D2552Q171

ISIN

DE000A11QW50

Country

DE

Price

1.6

Beta

0

Volume Avg.

580

Market Cap

0

Shares

-

52-Week

1.55-6.2

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-

P/B

-

Website

https://www.epigenomics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ECX.DE News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep